Stability, biofunctional, and antimicrobial characteristics of cannabidiol isolate for the design of topical formulations-Reference-Cited by-同舟云学术

Stability, biofunctional, and antimicrobial characteristics of cannabidiol isolate for the design of topical formulations

Published:2024 Issue:10 Volume:20 Page:2348-2360
ISSN:1744-683X
Container-title:Soft Matter
language:en
Short-container-title:Soft Matter

Author:

Kesavan Pillai Sreejarani¹^ORCID,Hassan Kera Nazia¹²^ORCID,Kleyi Phumelele¹^ORCID,de Beer Marinda¹^ORCID,Magwaza Matin³,Ray Suprakas Sinha¹²^ORCID

Affiliation:

1. Centre for Nanostructures and Advanced Materials, DSI-CSIR Nanotechnology Innovation Centre, Council for Scientific and Industrial Research, Pretoria 0001, South Africa

2. Department of Chemical Sciences, University of Johannesburg, Droonfontein 2028, Johannesburg, South Africa

3. Tautomer Bioscience Pty Ltd., 260 Cradock Ave, Lyttelton Manor, Centurion, 0157, South Africa

Abstract

Cannabidiol's stability and functional properties were investigated. The phytocannabinoid showed excellent antioxidant, anti-collagenase properties along with antimicrobial properties against Gram-positive bacterial and fungal species which suggest opportunities as an ingredient in topical products.

Funder

Council for Scientific and Industrial Research, South Africa

Department of Science and Innovation, South Africa

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/SM/D3SM01466E

Reference78 articles.

1. Cannabinoids in dermatology: a scoping review

2. Cannabinoids: from pot to lab

3. The growing trend of cannabidiol in skincare products

4. The Essential Medicinal Chemistry of Cannabidiol (CBD)

5. Quantification of the content of cannabidiol in commercially available e-liquids and studies on their thermal and photo-stability

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cannabinoids from C. sativa L.: Systematic Review on Potential Pharmacological Effects against Infectious Diseases Downstream and Multidrug-Resistant Pathogens;Future Pharmacology;2024-09-09